PROCEPT BioRobotics (PRCT) news
Recent news
Procept Birobotics Corporation: Leerink partners cuts target price to $20 from $21
Procept BioRobotics Corporation’s stock declined following the announcement of CEO Reza Zadno’s retirement, with the shares falling nearly 9% in response to the leadership transition . Larry Wood, a board member with extensive experience in cardiac medical devices, will assume the CEO role starting…
AInvest Wire · 5d agoProcept Birobotics Corporation: Barclays initiates coverage with overweight rating and target price $30
Barclays analyst Christopher Pasquale has initiated coverage on Procept BioRobotics Corporation (PRCT) with an "Overweight" rating and a $30 price target , signaling a positive outlook for the surgical robotics company. The firm highlighted Procept’s innovative AquaBeam Robotic System , which is…
AInvest Wire · 7d agoProcept Birobotics Corporation - Extends term loan maturity date to October 1, 2028 - SEC filing
AInvest Wire · Sep 24, 2026Procept Birobotics Corporation - Enters third amendment to loan and security agreement with CIBC - SEC filing
On September 24, 2026, Procept Biorobotics Corporation announced the execution of the third amendment to its loan and security agreement with CIBC, as disclosed in a recent SEC filing. The amendment modifies certain terms of the existing credit facility, which has supported the company’s operations…
AInvest Wire · Sep 24, 2026Procept Biorobotics Corp: Leerink Partners cuts target price to $21 from $29
Leerink Partners has revised its target price for Procept Biorobotics Corp (PRCT) from $29 to $21, maintaining a "Hold" rating for the stock. The downgrade reflects ongoing challenges in the company’s operational performance and market dynamics. PRCT, a commercial-stage surgical robotics firm,…
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.